Global Polycystic Kidney Disease Market Size To Worth USD 1.01 Billion By 2033 | CAGR of 5.70%
Category: HealthcareGlobal Polycystic Kidney Disease Market Size To Worth USD 1.01 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Polycystic kidney disease Market Size is to Grow from USD 0.58 Billion in 2023 to USD 1.01 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.70% during the projected period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the “Global Polycystic Kidney Disease Market Size, Share, and COVID-19 Impact Analysis, By Type (Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD)), By Diagnosis (Genetic Testing, Ultrasound, MRI, and CT scans), By Treatment (Drug Therapy, Dialysis, and Kidney Transplantation), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.” Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/polycystic-kidney-disease-market
Polycystic kidney disease (PKD) is a genetic condition where clusters of fluid-filled cysts develop in the kidneys, causing them to enlarge and lose function over time. The cysts, which can grow and multiply, lead to a progressive decline in kidney function, potentially resulting in kidney failure. Treatment focuses on managing symptoms, slowing disease progression, and addressing complications like high blood pressure, infections, and kidney stones. Drug therapies, such as tolvaptan, can help slow cyst growth, while other treatments include pain management and blood pressure control. In advanced stages, dialysis or kidney transplantation may be necessary. Lifestyle changes, including dietary adjustments and regular monitoring, are also important in managing PKD and improving the patient's quality of life. However, the downside of the treatment is that drug therapies like tolvaptan can be costly, may have significant side effects such as liver toxicity, and cannot cure the disease, only slow its progression.
The autosomal dominant polycystic kidney disease (ADPKD) segment is anticipated to hold the greatest share of the global polycystic kidney disease market during the projected timeframe.
Based on the type, the global polycystic kidney disease market is divided into autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD). Among these, the autosomal dominant polycystic kidney disease (ADPKD) segment is anticipated to hold the greatest share of the global polycystic kidney disease market during the projected timeframe. The segment is expected to experience significant growth due to advancements in drug therapies, increased awareness, and targeted therapies.
The genetic testing segment is anticipated to grow at the fastest pace in the global polycystic kidney disease market during the projected timeframe.
Based on the diagnosis, the global polycystic kidney disease market is divided into genetic testing, ultrasound, MRI, and CT scans. Among these, the genetic testing segment is anticipated to grow at the fastest pace in the global polycystic kidney disease market during the projected timeframe. Genetic testing for polycystic kidney disease (PKD) is expected to grow due to advancements in technology, early diagnosis awareness, and personalized medicine adoption.
The drug therapy segment is anticipated to grow at the fastest pace in the global polycystic kidney disease market during the projected timeframe.
Based on the treatment, the global polycystic kidney disease market is divided into drug therapy, dialysis, and kidney transplantation. Among these, the drug therapy system segment is anticipated to grow at the fastest pace in the global polycystic kidney disease market during the projected timeframe. The drug therapy segment is expected to experience significant growth in the polycystic kidney disease treatment market due to effective drugs, less invasive options, and ongoing research.
North America is expected to hold the largest share of the global polycystic kidney disease market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global polycystic kidney disease market over the forecast period. The region is going to dominate the market due to its advanced healthcare infrastructure, high awareness, research focus, leading pharmaceutical companies, ongoing clinical trials, innovative treatments, and substantial spending.
Asia Pacific is predicted to grow at the fastest pace in the global polycystic kidney disease market during the projected timeframe. The region’s polycystic kidney disease market is expected to experience rapid growth due to rising chronic kidney disease prevalence, healthcare investments, and improved access to advanced diagnostics and treatments.
Major vendors in the Global Polycystic Kidney Disease Market include Otsuka Pharmaceutical Co., Ltd., Sanofi, Johnson & Johnson, Novartis AG, AbbVie Inc., AstraZeneca, Merck & Co., Inc., Pfizer Inc., Bayer AG, Reata Pharmaceuticals, Inc., Eli Lilly and Company, Galapagos NV, Vertex Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline plc (GSK), and Others.
Recent Developments
- In May 2022, Regulus Therapeutics received FDA approval for its Investigational New Drug Application for RGLS8429, a treatment for Autosomal Dominant Polycystic Kidney Disease.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Polycystic kidney disease Market based on the below-mentioned segments:
Global Polycystic Kidney Disease Market, By Type
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Global Polycystic Kidney Disease Market, By Diagnosis
- Genetic Testing
- Ultrasound
- MRI
- CT Scans
Global Polycystic Kidney Disease Market, By Treatment
- Drug Therapy
- Dialysis
- Kidney Transplantation
Global Polycystic Kidney Disease Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?